<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"><channel><title>Aggrenox</title><link>http://www.unboundmedicine.com/medline/ebm/research/Aggrenox</link><description>Unbound MEDLINE is a service provided by Unbound Medicine, Inc. that includes data and services from the U.S. National Library of Medicine's MEDLINE® and PubMed® databases.</description><language>en-us</language><copyright>Unbound Medicine, Inc.</copyright><item><title>[Guidelines recommend aspirin/dipyridamole retard in high recurrence risk. Well protected from the second stroke]</title><link>http://www.unboundmedicine.com/medline/ebm/record/19722467/full_citation/[Guidelines_recommend_aspirin/dipyridamole_retard_in_high_recurrence_risk__Well_protected_from_the_second_stroke]</link><description>Schwab S <br/><span class="title">[Guidelines recommend aspirin/dipyridamole retard in high recurrence risk. Well protected from the second stroke] [Journal Article]</span><br/><span class="source" title="MMW Fortschritte der Medizin">MMW Fortschr Med 2009 Jul 23; 151(30-33):60-1.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19722467/full_citation/[Guidelines_recommend_aspirin/dipyridamole_retard_in_high_recurrence_risk__Well_protected_from_the_second_stroke]">Full Citation</a> | <a rel="nofollow" href="http://www.unboundmedicine.com/medline/ebm/related/19722467/[Guidelines_recommend_aspirin/dipyridamole_retard_in_high_recurrence_risk__Well_protected_from_the_second_stroke]">Find Related Articles</a> </description></item><item><title>Distribution of dipyridamole in blood components among post-stroke patients treated with extended release formulation.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19718475/full_citation/Distribution_of_dipyridamole_in_blood_components_among_post_stroke_patients_treated_with_extended_release_formulation_</link><description>Serebruany V, Sabaeva E, Booze C, et al. <br/><span class="title">Distribution of dipyridamole in blood components among post-stroke patients treated with extended release formulation. [JOURNAL ARTICLE]</span><br/><span class="source" title="Thrombosis and haemostasis">Thromb Haemost 2009; 102(3):538-543.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19718475/abstract/Distribution_of_dipyridamole_in_blood_components_among_post_stroke_patients_treated_with_extended_release_formulation_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19718475/full_citation/Distribution_of_dipyridamole_in_blood_components_among_post_stroke_patients_treated_with_extended_release_formulation_">Full Citation</a></description></item><item><title>Combination antiplatelet therapy for secondary stroke prevention: enhanced efficacy or double trouble?</title><link>http://www.unboundmedicine.com/medline/ebm/record/19361598/full_citation/Combination_antiplatelet_therapy_for_secondary_stroke_prevention:_enhanced_efficacy_or_double_trouble</link><description>Usman MH, Notaro LA, Nagarakanti R, et al. <br/><span class="title">Combination antiplatelet therapy for secondary stroke prevention: enhanced efficacy or double trouble? [Journal Article, Review]</span><br/><span class="source" title="The American journal of cardiology">Am J Cardiol 2009 Apr 15; 103(8):1107-12.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19361598/abstract/Combination_antiplatelet_therapy_for_secondary_stroke_prevention:_enhanced_efficacy_or_double_trouble">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19361598/full_citation/Combination_antiplatelet_therapy_for_secondary_stroke_prevention:_enhanced_efficacy_or_double_trouble">Full Citation</a> | <a href="http://linkinghub.elsevier.com/retrieve/pii/S0002-9149(09)00033-2">Publisher Full Text</a> | <a rel="nofollow" href="http://www.unboundmedicine.com/medline/ebm/related/19361598/Combination_antiplatelet_therapy_for_secondary_stroke_prevention:_enhanced_efficacy_or_double_trouble">Find Related Articles</a> </description></item><item><title>Aggrenox (Asasantin retard)-induced Stevens-Johnson syndrome.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19094159/full_citation/Aggrenox__Asasantin_retard__induced_Stevens_Johnson_syndrome_</link><description>Jao T, Tsai TH, Jeng JS <br/><span class="title">Aggrenox (Asasantin retard)-induced Stevens-Johnson syndrome. [JOURNAL ARTICLE]</span><br/><span class="source" title="British journal of clinical pharmacology">Br J Clin Pharmacol 2008 Dec 16.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19094159/full_citation/Aggrenox__Asasantin_retard__induced_Stevens_Johnson_syndrome_">Full Citation</a> | <a href="http://dx.doi.org/10.1111/j.1365-2125.2008.03340.x">Publisher Full Text</a> | <a rel="nofollow" href="http://www.unboundmedicine.com/medline/ebm/related/19094159/Aggrenox__Asasantin_retard__induced_Stevens_Johnson_syndrome_">Find Related Articles</a> </description></item><item><title>[Current issues of anticoagulant therapy and dental treatment]</title><link>http://www.unboundmedicine.com/medline/ebm/record/19055130/full_citation/[Current_issues_of_anticoagulant_therapy_and_dental_treatment]</link><description>Joób-Fancsaly A, Barabás JB, Horváth C, et al. <br/><span class="title">[Current issues of anticoagulant therapy and dental treatment] [English Abstract, Journal Article]</span><br/><span class="source" title="">Fogorv Sz 2008 Aug; 101(4):147-53.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19055130/abstract/[Current_issues_of_anticoagulant_therapy_and_dental_treatment]">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19055130/full_citation/[Current_issues_of_anticoagulant_therapy_and_dental_treatment]">Full Citation</a></description></item><item><title>Does Aggrenox (aspirin/dipyridamole) reduce the risk of recurrent stroke to a greater degree than aspirin alone?</title><link>http://www.unboundmedicine.com/medline/ebm/record/18678202/full_citation/Does_Aggrenox__aspirin/dipyridamole__reduce_the_risk_of_recurrent_stroke_to_a_greater_degree_than_aspirin_alone</link><description>Hoover PL, Mold JW <br/><span class="title">Does Aggrenox (aspirin/dipyridamole) reduce the risk of recurrent stroke to a greater degree than aspirin alone? [Journal Article]</span><br/><span class="source" title="The Journal of the Oklahoma State Medical Association">J Okla State Med Assoc 2008 May; 101(5):80-2.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/18678202/full_citation/Does_Aggrenox__aspirin/dipyridamole__reduce_the_risk_of_recurrent_stroke_to_a_greater_degree_than_aspirin_alone">Full Citation</a> | <a rel="nofollow" href="http://www.unboundmedicine.com/medline/ebm/related/18678202/Does_Aggrenox__aspirin/dipyridamole__reduce_the_risk_of_recurrent_stroke_to_a_greater_degree_than_aspirin_alone">Find Related Articles</a> </description></item><item><title>Secondary stroke prevention set to benefit from PRoFESS trial.</title><link>http://www.unboundmedicine.com/medline/ebm/record/18568182/full_citation/Secondary_stroke_prevention_set_to_benefit_from_PRoFESS_trial_</link><description><span class="title">Secondary stroke prevention set to benefit from PRoFESS trial. [Journal Article]</span><br/><span class="source" title="Cardiovascular journal of Africa">Cardiovasc J Afr 2008 May-Jun; 19(3):165.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/18568182/full_citation/Secondary_stroke_prevention_set_to_benefit_from_PRoFESS_trial_">Full Citation</a></description></item><item><title>Correction to the PRoFESS Trial paper by Diener et al. (Cerebrovasc Dis 2007;23:368-80.</title><link>http://www.unboundmedicine.com/medline/ebm/record/18416019/full_citation/Correction_to_the_PRoFESS_Trial_paper_by_Diener_et_al___Cerebrovasc_Dis_2007;23:368_80_</link><description>Sacco R, Diener HC, Yusuf S <br/><span class="title">Correction to the PRoFESS Trial paper by Diener et al. (Cerebrovasc Dis 2007;23:368-80. [Journal Article, Published Erratum]</span><br/><span class="source" title="Cerebrovascular diseases (Basel, Switzerland)">Cerebrovasc Dis 2008; 25(1-2):192.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/18416019/full_citation/Correction_to_the_PRoFESS_Trial_paper_by_Diener_et_al___Cerebrovasc_Dis_2007;23:368_80_">Full Citation</a> | <a rel="nofollow" href="http://www.unboundmedicine.com/medline/ebm/related/18416019/Correction_to_the_PRoFESS_Trial_paper_by_Diener_et_al___Cerebrovasc_Dis_2007;23:368_80_">Find Related Articles</a> </description></item><item><title>Antiplatelet profiles of the fixed-dose combination of extended-release dipyridamole and low-dose aspirin compared with clopidogrel with or without aspirin in patients with type 2 diabetes and a history of transient ischemic attack: A randomized, single-blind, 30-day trial.</title><link>http://www.unboundmedicine.com/medline/ebm/record/18343263/full_citation/Antiplatelet_profiles_of_the_fixed_dose_combination_of_extended_release_dipyridamole_and_low_dose_aspirin_compared_with_clopidogrel_with_or_without_aspirin_in_patients_with_type_2_diabetes_and_a_history_of_transient_ischemic_attack:_A_randomized_single_blind_30_day_trial_</link><description>Serebruany VL, Malinin AI, Pokov AN, et al. <br/><span class="title">Antiplatelet profiles of the fixed-dose combination of extended-release dipyridamole and low-dose aspirin compared with clopidogrel with or without aspirin in patients with type 2 diabetes and a history of transient ischemic attack: A randomized, single-blind, 30-day trial. [JOURNAL ARTICLE]</span><br/><span class="source" title="Clinical therapeutics">Clin Ther 2008 Feb; 30(2):249-259.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/18343263/abstract/Antiplatelet_profiles_of_the_fixed_dose_combination_of_extended_release_dipyridamole_and_low_dose_aspirin_compared_with_clopidogrel_with_or_without_aspirin_in_patients_with_type_2_diabetes_and_a_history_of_transient_ischemic_attack:_A_randomized_single_blind_30_day_trial_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/18343263/full_citation/Antiplatelet_profiles_of_the_fixed_dose_combination_of_extended_release_dipyridamole_and_low_dose_aspirin_compared_with_clopidogrel_with_or_without_aspirin_in_patients_with_type_2_diabetes_and_a_history_of_transient_ischemic_attack:_A_randomized_single_blind_30_day_trial_">Full Citation</a> | <a href="http://linkinghub.elsevier.com/retrieve/pii/S0149-2918(08)00089-1">Publisher Full Text</a> | <a rel="nofollow" href="http://www.unboundmedicine.com/medline/ebm/related/18343263/Antiplatelet_profiles_of_the_fixed_dose_combination_of_extended_release_dipyridamole_and_low_dose_aspirin_compared_with_clopidogrel_with_or_without_aspirin_in_patients_with_type_2_diabetes_and_a_history_of_transient_ischemic_attack:_A_randomized_single_blind_30_day_trial_">Find Related Articles</a> </description></item><item><title>Randomized clinical stroke trials in 2006.</title><link>http://www.unboundmedicine.com/medline/ebm/record/18220941/full_citation/Randomized_clinical_stroke_trials_in_2006_</link><description>Rabadi MH, Blass JP <br/><span class="title">Randomized clinical stroke trials in 2006. [Journal Article]</span><br/><span class="source" title="Current vascular pharmacology">Curr Vasc Pharmacol 2008 Jan; 6(1):61-6.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/18220941/abstract/Randomized_clinical_stroke_trials_in_2006_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/18220941/full_citation/Randomized_clinical_stroke_trials_in_2006_">Full Citation</a> | <a rel="nofollow" href="http://www.unboundmedicine.com/medline/ebm/related/18220941/Randomized_clinical_stroke_trials_in_2006_">Find Related Articles</a> </description></item></channel></rss>